Bevasiranib sodium - CAS 849758-52-7

Catalog number: BRC-019

Bevasiranib sodium is a siRNA designed to silence the genes that produce vascular endothelial growth factor (VEGF) . It is widely accepted that vascular endothelial growth factor (VEGF) is a key component in the pathogenesis of choroidal neo-vascularization (CNV), which is a precursor to wet age-related macular degeneration (wet AMD).

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
Powder: -20°C for 3 years; In solvent: -80°C for 2 years
Related Products
Online Inquiry
Verification code
Inquiry Basket